4//SEC Filing
Levine Mark S. 4
Accession 0001764013-24-000141
CIK 0001764013other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:17 PM ET
Size
5.9 KB
Accession
0001764013-24-000141
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Levine Mark S.
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-07-24$27.76/sh−4,015$111,456→ 333,394 total
Footnotes (2)
- [F1]On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 8,938 of these RSUs vested on July 19, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.37 - $28.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001617236
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 4:17 PM ET
- Size
- 5.9 KB